EMA
approval
· 2025-11-14
First gene therapy to treat rare disease Wiskott-Aldrich syndrome
Summary
The EMA has approved the first gene therapy for Wiskott-Aldrich syndrome (Waskyra), which significantly reduces infections and bleeding episodes in affected ind…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Waskyra significantly reduces infections and bleeding episodes in people with life-threatening immunodeficiency